Executive physical marketing: comprehensive claims, screening tests and employer privacy

An executive physical is a long, scheduled visit for a person who feels well: an extended history and exam, a lab panel, tests such as an ECG or imaging, a fitness assessment and a review with a physician, in a single day. The buyer is the patient or, for a perk offered to leaders, their employer. The ad has two jobs: explain what the day includes, and avoid promising more than any set of tests can deliver.

Two related topics have their own guides and are not repeated here. Membership models, access promises and retainer fees are in our concierge medicine marketing guide. Selling screenings and wellness programs to employers, including the HIPAA wellness program, ADA and GINA rules and aggregate reporting, is in our corporate wellness program marketing guide. This guide covers what is specific to the executive physical: the comprehensive and early detection claims, how to describe the tests in the package, and who receives the results when an employer pays. Practices that contract with employers directly should read direct employer contracting.

Why comprehensive and early detection claims need care

Under 15 U.S.C. 45, deceptive acts or practices in commerce are unlawful, and 15 U.S.C. 52 makes it unlawful to disseminate a false advertisement to induce the purchase of drugs, devices or services. The FTC Health Products Compliance Guidance explains how the agency applies those laws to health claims. Three of its points apply directly to an executive physical:

• Claims about health benefits must be supported by “competent and reliable scientific evidence”, and the guidance says that, as a general matter, substantiation of health-related benefits will need to be randomized, controlled human clinical testing.
• When an ad can reasonably be read more than one way, the advertiser is responsible for substantiating each reasonable reading.
• An ad makes implied claims through images and context as well as through words.

Words such as “comprehensive”, “head to toe” or “leave nothing to chance” invite a reading that the day will find any problem the patient has. “Catch disease early” and “find problems before they find you” add a second reading: that finding something earlier will change the outcome. Each of those readings is a health benefit claim. Neither is supported by the fact that a package contains a long list of tests.

Describe the day by what it contains and what happens next: which exams and tests are included, who performs and reads them, how the results are explained, and what follow-up is offered. That is checkable, and it gives the patient a better picture than a promise.

What the USPSTF says about tests in people without symptoms

The U.S. Preventive Services Task Force grades preventive services by the balance of benefits and harms. In its Grade Definitions, a D grade means the Task Force recommends against the service because there is moderate or high certainty that the service has no net benefit or that the harms outweigh the benefits. An I statement means the current evidence is insufficient to assess the balance of benefits and harms. Three statements cover tests that executive packages can include:

• Resting or exercise ECG. In its statement of June 12, 2018, the Task Force recommends against screening with resting or exercise ECG to prevent cardiovascular disease events in asymptomatic adults at low risk (grade D), and finds the evidence insufficient for asymptomatic adults at intermediate or high risk (I statement). It lists harms including unnecessary invasive procedures, overtreatment and labeling.
• Ankle-brachial index, hsCRP and coronary artery calcium score. In its statement of July 10, 2018, the Task Force concludes that the evidence is insufficient to assess the balance of benefits and harms of adding these to traditional risk assessment in asymptomatic adults (I statement). The page notes an update in progress for coronary artery calcium scoring, so check it again before you cite it.
• Carotid artery ultrasound. In its statement of February 2, 2021, the Task Force recommends against screening for asymptomatic carotid artery stenosis in the general adult population (grade D), and says it found that the harms of screening outweigh the benefits.

These statements are about screening people without symptoms. They do not decide what a clinician orders for a patient with symptoms or a known risk, and they do not ban a test. They do shape the marketing. If a package page presents a test as a way to find heart disease or stroke risk early, and the Task Force recommends against that test for the person reading the ad, the claim is hard to support. Quote the statement as written and dated, describe who it applies to, and do not invent a grade for a test the Task Force has not reviewed.

A safer pattern is to explain that the physician decides which tests are appropriate for each patient based on age, history and risk, and that some tests in the package are offered only when the physician finds a reason for them. If imaging beyond the standard exam is part of the offer, our full-body MRI marketing guide covers the FDA and ACR statements on scanning people without symptoms. Lab panels sold directly to patients are covered in our direct-to-consumer lab testing guide.

Glaucoma checks show why the USPSTF wording matters: the Task Force issued an I statement on screening adults without symptoms, while NEI recommends dilated exams for people at higher risk. Our guide to glaucoma practice marketing covers how to quote both without blurring them.

Follow-up and incidental findings

The USPSTF statement on nontraditional risk factors lists harms that include abnormal test results, incidental findings leading to additional testing and possible procedures, and anxiety. A package that bundles several tests in one day should tell the patient, before they pay, what happens when a result is abnormal or unexpected:

• Who explains the result and when.
• Whether follow-up visits, repeat tests or referrals are included in the price or billed separately.
• Whether further testing would go through the patient’s insurance or be self-pay.
• How the results reach the patient’s own primary care clinician, with the patient’s permission.

When an employer pays: who gets the results

An employer that buys executive physicals for its leaders will ask what it receives. The HHS page Employers and Health Information in the Workplace says that in general the HIPAA Privacy Rule applies to disclosures made by a health care provider, not to the questions an employer may ask, and that if an employer asks a provider directly for information about a person, the provider cannot give it without the person’s authorization unless other laws require it. Under 45 CFR 164.508, that authorization must be written and must contain the elements the rule lists.

For marketing to employers, that means:

• Do not promise the employer individual results, a fitness for duty opinion or a list of findings as part of the package. That is a separate service with its own rules; see our occupational medicine marketing guide.
• Say plainly in the proposal that results go to the patient, and that anything shared with the employer requires the patient’s written authorization.
• If the employer wants confirmation that a visit took place, decide with counsel what that confirmation contains and whether it needs an authorization.
• If the program runs through the employer’s group health plan, health plan privacy and ERISA rules can apply as well; have counsel review the arrangement. The plan and aggregate reporting rules are in our corporate wellness guide linked above.

Claims to an employer need the same care as claims to a patient. A figure for fewer sick days, lower claims costs or leadership retention is an outcome claim. Do not put one in a proposal unless you hold evidence for that claim for programs like yours.

Prices and packages

Executive physicals are sold as a day with a price, and patients compare them. If you advertise a price, say what it includes and what it does not: which tests, the number of physician visits, follow-up, and whether imaging or specialist consultations are extra. Self-pay patients may be entitled to a good faith estimate; see our guide to good faith estimates for self-pay patients. If the physical is bundled into an annual membership that renews automatically, see our guide to membership auto-renewal rules. Shorter physicals such as DOT and sports exams raise their own wording questions; see our guide to DOT and sports physical marketing.

Stories, endorsements and tracking

A story about a test that found a problem is persuasive, and it is the kind of story that carries the early detection claim the FTC guidance asks you to support. Under 16 CFR 255.2, an ad that presents one person’s experience on a key point is likely to be read as showing what others will experience, and without substantiation that the result is representative, the ad should clearly disclose the generally expected results. A patient’s story or results held by the practice are protected health information, and 45 CFR 164.508 generally requires written authorization before using them in marketing; see our guide to patient testimonials and before-and-after photos. Booking and intake pages for a health assessment should keep health information away from ad tracking tools; see our guide to tracking pixels on practice websites.

Illustration: two ways to advertise an executive physical

Illustration: [Clinic name] runs an ad that reads “A complete physical with nothing missed. Full cardiac and vascular screening catches heart disease and stroke risk before symptoms appear. Your company gets a full report.” The page lists a stress ECG, a carotid ultrasound and a calcium score for every patient, and shows a patient quote about a test that saved their life. The ad makes comprehensive and early detection claims the clinic cannot support, presents tests the Task Force recommends against or finds insufficient evidence for in people without symptoms as routine screening, uses an unrepresentative story without a disclosure, and promises the employer results it cannot share without authorization.

Illustration: [Clinic name] runs an ad that reads “A one-day physician assessment. Extended history and exam, labs, a fitness assessment and a written plan reviewed with you.” The page lists what the day includes and costs, says the physician decides which additional tests fit each patient’s age, history and risk, explains how abnormal results and follow-up are handled and billed, and states that results go only to the patient unless they authorize sharing in writing. The employer proposal describes the service and offers no outcome figures.

Checklist before an executive physical campaign goes live

• No “comprehensive”, “head to toe” or “catch disease early” claims unless the evidence meets the FTC standard for each reasonable reading.
• Tests in the package described by what they are and when the physician orders them, not as screening for people without symptoms where the USPSTF recommends against it or finds the evidence insufficient.
• Any USPSTF statement quoted as written, with its date, and rechecked before launch.
• Follow-up, incidental findings and what is billed separately explained before payment.
• Prices state what is included and excluded, with good faith estimate and renewal rules checked.
• Employer proposals state that results go to the patient and that sharing requires written authorization under 45 CFR 164.508.
• No savings, sick day or retention figures in employer proposals without evidence for that claim.
• Patient stories have written authorization and a disclosure of generally expected results.
• Booking and intake pages keep health information away from ad tracking tools.

How we help

We build websites, local search, Google Ads and AI front desk tools for independent practices and health businesses. For an executive physical program, that means service pages that list what the day includes rather than promise what it will find, search content written around the questions patients and employers ask before they book, and inquiry and booking forms that keep health information away from tracking tools. We do not decide which tests a patient should have or whether a claim is substantiated; your clinicians and counsel do. Our tools are built with HIPAA in mind. We confirm in writing what a BAA covers before any patient information flows through a tool, and if it is not covered, we do not route patient information through it. We are not a healthcare provider and we do not give legal or medical advice. We do not sell lead lists and we do not pay for referrals. For the wider rules, see our healthcare marketing rules hub.

Sources

• 15 U.S.C. 45: Unfair methods of competition and unfair or deceptive acts or practices
• 15 U.S.C. 52: Dissemination of false advertisements
• FTC: Health Products Compliance Guidance (December 2022)
• USPSTF: Grade Definitions
• USPSTF: Cardiovascular Disease Risk: Screening With Electrocardiography (June 12, 2018)
• USPSTF: Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors (July 10, 2018)
• USPSTF: Asymptomatic Carotid Artery Stenosis: Screening (February 2, 2021)
• HHS: Employers and Health Information in the Workplace (content last reviewed November 2, 2020)
• 16 CFR 255.2: Consumer endorsements
• 45 CFR 164.508: Uses and disclosures for which an authorization is required

More in Cash-pay, aesthetic and wellness care